Homocysteine elevation in givosiran treatment: Suggested ALAS1 siRNA effect on cystathionine beta‐synthase

Author(s):  
Daphne Vassiliou ◽  
Eliane Sardh
2016 ◽  
Vol 17 (13) ◽  
pp. 1455-1470 ◽  
Author(s):  
Tomas Majtan ◽  
Angel L. Pey ◽  
June Ereño-Orbea ◽  
Luis Alfonso Martínez-Cruz ◽  
Jan P. Kraus

1992 ◽  
Vol 267 (16) ◽  
pp. 11455-11461
Author(s):  
M Swaroop ◽  
K Bradley ◽  
T Ohura ◽  
T Tahara ◽  
M.D. Roper ◽  
...  

2001 ◽  
Vol 28 (5) ◽  
pp. 145-151 ◽  
Author(s):  
Ursula Trondle1 ◽  
G. Sunder-Plassmann2 ◽  
H. Burgmann3 ◽  
Heidi Buchmayer1 ◽  
L. Kramer4 ◽  
...  

2021 ◽  
Vol 24 (10) ◽  
pp. 309-313
Author(s):  
Aldo Ravaglia ◽  
Giulia Costagliola ◽  
Marco Spada

Classical homocystinuria is an inborn error of methionin metabolism. It is characterized by an accumulation of homocysteine, due to a deficiency of the enzyme involved in its metabolism, namely cystathionine beta synthase. If not treated, the increase in homocysteine leads to a multisystem syndrome that involves connective tissue, nervous and vascular systems with a predisposition to thromboembolism and developmental delay in childhood. An early diagnosis allows the specific therapy to be promptly started and prevents the classical manifestations of the disease. Since 2016 in Italy homocystinuria detection has been included in the expanded newborn screening. However, it is important not to forget this disease, because of its severe consequences of an untreated condition on the quality and expectancy of life.


2018 ◽  
Vol 28 (4) ◽  
pp. 311-323 ◽  
Author(s):  
Tomas Majtan ◽  
Jakub Krijt ◽  
Jitka Sokolová ◽  
Michaela Křížková ◽  
Maria A. Ralat ◽  
...  

2000 ◽  
Vol 40 (supplement) ◽  
pp. S178
Author(s):  
Y. Kamikozawa ◽  
T. Tomita ◽  
M. Sato ◽  
T. Yosida ◽  
M. Saito

2001 ◽  
Vol 18 (6) ◽  
pp. 548-549 ◽  
Author(s):  
J. Sokolová ◽  
B. Janošíková ◽  
J.D. Terwilliger ◽  
T. Freiberger ◽  
J. P. Kraus ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document